Attachement - Qualification Process for Drug Development Tools: Qualification of Exacerbations of Chronic Pulmonary Disease Tool for Measurement of Symptoms of Acute Bacterial Exacerbation of Chronic Bronchitis in Patients With Chronic Obstructive Pulmonary Disease
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
January 10, 2014
April 29, 2020
88815054-17fc-4e46-a5c1-be7b0bad1ea9
Related Documents
Reporting Drug Sample Information Under Section 6004 of the Affordable Care Act
Guidance DocumentJuly 11, 2014Center for Drug Evaluation and Research
Drug Interaction Information in Human Prescription Drug and Biological Product Labeling
Guidance DocumentOctober 21, 2024Center for Drug Evaluation and Research
Evaluating Respiratory Symptoms in Chronic Obstructive Pulmonary Disease, a Patient-Reported Outcome Instrument for the Measurement of Severity of Respiratory Symptoms in Stable Chronic Obstructive Pulmonary Disease: Qualification for Exploratory Use
Guidance DocumentMarch 1, 2016Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.